After directly examining major experimental cities around the world, such as Wuhan in China, Singapore, and Dubai, reporters ...

The International Liaison Committee on Resuscitation conducts continuous reviews of new, peer-reviewed published ...

Daiichi Sankyo Company, Limited ( OTCPK:DSNKY) Discusses ESMO 2025 Highlights With Focus on Key Breast Cancer Trial Data and Regulatory Submissions October 21, 2025 8:00 AM EDT ...

Introduction The number of people living with dementia is increasing worldwide. Alzheimer’s disease (AD) is the most common type of dementia. It typically manifests itself initially with cognitive ...

Researchers led by Professor Yvonne Nolan at University College Cork have identified specific metabolic pathways ...

Camrelizumab and famitinib are projected to achieve global annual sales of $463 million and $108 million by 2031.

Background: Depression negatively affects how a person feels, thinks, or behaves; is associated with impaired functioning in social and work settings; and can be associated with thoughts of suicide.

Alphamab Oncology (stock code: 9966.HK) announced that two latest clinical data on biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 for the treatment of primary platinum-refractory ...

After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in ...

A New Era in the Treatment of Muscle Invasive Bladder Cancer. Discussant of LBA2 - Perioperative (Periop) Enfortumab Vedotin ...

Although practice guidelines such as those from SurvivingSepsis.org have helped to reduce mortality and complications, sepsis ...

Detailed price information for Nurexone Biologic Inc (NRX-X) from The Globe and Mail including charting and trades.